Related Experiment Videos
BMP7 signaling in renal development and disease
Sanjeevkumar R Patel1, Gregory R Dressler
1Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Trends in Molecular Medicine
|October 12, 2005
Summary
Tubulointerstitial fibrosis, common in chronic kidney disease, is driven by transforming growth factor-beta. Bone morphogenetic protein 7 (BMP7) counteracts this fibrosis, with its activity modulated by extracellular binding proteins.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Tubulointerstitial fibrosis is a hallmark of chronic kidney diseases.
- Transforming growth factor-beta (TGF-β) is a key mediator of fibrosis, causing myofibroblast proliferation and collagen deposition.
- Extracellular binding proteins regulate TGF-β superfamily signaling.
Purpose of the Study:
- To elucidate the mechanisms of tubulointerstitial fibrosis.
- To investigate the role of BMP7 in counteracting TGF-β-mediated fibrosis.
- To understand the regulatory role of extracellular ligand binding proteins.
Main Methods:
- Utilized various mouse models of renal disease.
- Analyzed the expression and function of TGF-β and BMP7.
- Studied the impact of extracellular ligand binding proteins on receptor-ligand interactions.
Main Results:
- TGF-β expression was identified as a primary driver of fibrosis in mouse models.
- BMP7 demonstrated antifibrotic effects, counteracting TGF-β-induced fibrosis.
- Extracellular binding proteins were shown to modulate the activity of secreted factors.
Conclusions:
- TGF-β is a critical factor in the pathogenesis of tubulointerstitial fibrosis.
- BMP7 represents a potential therapeutic target for mitigating renal fibrosis.
- Regulation of growth factor activity by binding proteins is crucial in fibrotic processes.